Moolec Science (MLECW) Receivables - Other (2022 - 2026)
Moolec Science (MLECW) posted Receivables - Other of $5.2 million for Q1 2026, up 23.81% sequentially from $4.2 million in Q4 2025.
Moolec Science (MLECW) Receivables - Other (2022 - 2026) Analysis & Trends
Moolec Science has reported Receivables - Other for 5 years, with the latest figure at $5.2 million in Q1 2026.
- Quarterly Receivables - Other changed N/A year-over-year to $5.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.2 million (changed N/A YoY) and the FY2025 annual result came in at $13.8 million, down 60.04% from the prior year.
- Receivables - Other improved to $5.2 million in Q1 2026 per MLECW's latest filing, from $4.2 million in the prior quarter.
- Over five years, Receivables - Other peaked at $34.7 million in Q2 2024 and troughed at $2061.0 in Q2 2022.
- A 5-year average of $5.6 million and a median of $1.2 million in 2024 frame the typical range for Receivables - Other.
- The sharpest annual moves came in 2023 and 2025: Receivables - Other jumped 425083.26% in 2023, then slumped 60.04% in 2025.
- Over 5 years, Receivables - Other stood at $3876.0 in 2022, then jumped by 23517.88% to $915429.0 in 2023, then slipped by 11.65% to $808795.0 in 2024, then soared by 419.29% to $4.2 million in 2025, then gained by 23.81% to $5.2 million in 2026.
- According to Business Quant data, Receivables - Other over the past three periods registered $5.2 million, $4.2 million, and $13.8 million for Q1 2026, Q4 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Moolec Science | 8,617.72 | -1.19 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.20 Mn |
| Mar 31, 2026 | 5.20 Mn |
| Dec 31, 2025 | 4.20 Mn |
| Dec 31, 2025 | 4.20 Mn |
| Jun 30, 2025 | 13.85 Mn |
| Jun 30, 2025 | 13.85 Mn |
| Dec 31, 2024 | 808,795.00 |
| Dec 31, 2024 | 808,795.00 |
| Sep 30, 2024 | 1.07 Mn |
| Sep 30, 2024 | 1.07 Mn |
| Jun 30, 2024 | 34.66 Mn |
| Jun 30, 2024 | 34.66 Mn |
| Mar 31, 2024 | 1.19 Mn |
| Mar 31, 2024 | 1.19 Mn |
| Dec 31, 2023 | 915,429.00 |
| Dec 31, 2023 | 915,429.00 |
| Sep 30, 2023 | 1.31 Mn |
| Sep 30, 2023 | 1.31 Mn |
| Jun 30, 2023 | 8.76 Mn |
| Jun 30, 2023 | 8.76 Mn |